This 1957 Lancet case series describes two patients: a 63-year-old woman who developed anuric acute renal failure after vaginal hysterectomy, complicated by profuse diarrhoea and staphylococcal enteritis, with unrecordable blood pressure resistant to methylamphetamine; and a 49-year-old man in diabetic ketosis who became oliguric and pulseless with a blood-urea of 160 mg/100 ml. In both, an intravenous L-noradrenaline ('Levophed') infusion rapidly raised systolic pressure to ~130 mm Hg β Case 1 requiring initially ~40 Β΅g/min, peaking at 73 Β΅g/min, then tapering to 4 Β΅g/min before cessation at 86 hours without side-effects . Case 2 received ~20 Β΅g/min with an immediate pressure rise and increased urine output. Diuresis in Case 1 started on day 11 of severe oliguria.
The authors confront the physiological objection directly: Nickel et al. and Lathem showed noradrenaline reduces renal blood-flow while raising urine output in normals and chronic renal disease, implying intrarenal vasoconstriction and relative tubular ischaemia . Their counterargument β that restoring systemic pressure increases renal perfusion and outweighs local vasoconstriction β is biologically plausible but empirically untested here; the authors themselves state it is impossible to prove noradrenaline had no deleterious renal effect .
The paper's most durable value is operational: a dosage philosophy (titrate to systolic ~130 mm Hg; typical initial range 10β30 Β΅g/min; double or treble concentration rather than drip-rate in anuric patients to avoid over-hydration), a dosing chart relating drip-rate to drug concentration, and a venous necrosis-avoidance technique (deep Polythene cannulation of an ankle vein for >80 hours, watching for skin bluish discoloration) .
Modern nephrology's dominant framing β vasopressor support via norepinephrine in shock with careful perfusion targets β retrospectively vindicates the direction of the authors' conjecture, but properly controlled trials, not these cases, established it. The paper's claims would be falsified by showing that normotensive restoration without noradrenaline fails to restore urine output in oliguric shock, or that higher rates of renal non-recovery follow norepinephrine versus other vasopressors in randomized settings. Neither test was possible in 1957, and this paper makes no attempt at either β which is exactly why it should be read as a hypothesis source, not evidence.
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.